important periprocedural myocardial injury after cardiac surgery, but consensus recommendations regarding the threshold levels range widely (from >10 times to ≥70 times the upper reference limit for the assay). MORE

Robert Rutherford MD was an iconic leader in the history of vascular surgery in this country and internationally. This book, which is one of his many contributions to the field, carries on his legacy of leadership as the preeminent, most definitive, and encyclopedic and most widely respected text in the field of vascular surgical disease. This text is truly unique in the field in its multidisciplinary and international authorship, and its up-to-date comprehensive coverage of the art and science of circulatory disease. Dr. Sidawy and I as co-editors have been honored to be entrusted with the legacy of the Rutherford textbook, and have focused our energy on maintaining the highest quality of coverage of the field, while improving the presentation and value for the readership in the 10th edition through a very contemporary approach. MORE

Debra L. Beck, MSc, and Eugene Braunwald, MD Mineralocorticoid receptor antagonists (MRA) have a class IA recommendation in patients with heart failure with reduced ejection fraction (HFrEF) but are not commonly used in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D), in part because there have been no prospective evaluation of theirMORE

Physicians tend to be reluctant to integrate medicinal herbs into their care of patients for two main reasons: unfamiliarity with herbs and a sense that scientific evidence for medicinal herbs is lacking. This book is written to address such obstacles. It is uniquely written by a physician for physicians and other providers of conventional medical care. MORE